{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:10:15Z","timestamp":1761718215604,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.eplepsyres.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T09:46:15Z","timestamp":1334569575000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials"],"prefix":"10.1016","volume":"101","author":[{"given":"Roger J.","family":"Porter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gil-Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"DeRossett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2005.tb00033.x","article-title":"Retigabine: chemical synthesis to clinical application","volume":"11","author":"Blackburn-Munro","year":"2005","journal-title":"CNS Drug. Rev."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.metabol.2006.01.006","article-title":"N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II","volume":"55","author":"Borlak","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0020","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/WNL.0b013e3181fd6170","article-title":"Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy","volume":"75","author":"Brodie","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0025","first-page":"1","article-title":"Third-generation antiepileptic drugs for partial-onset seizures: lacosamide, retigabine, and eslicarbazepine acetate","volume":"1","author":"Chung","year":"2009","journal-title":"Eur. Neurol. J."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/14656561003709755","article-title":"Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last","volume":"11","author":"Cretin","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0035","unstructured":"European Medicines Agency, 2010. Guideline on Clinical Investigation of Medicinal Products in the Treatment of Epileptic Disorders (CHMP\/EWP\/566\/98 Rev.2\/Corr). European Medicines Agency, London, UK."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00912700222011210","article-title":"Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers","volume":"42","author":"Ferron","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.0b013e3182194bd3","article-title":"Randomized double-blind placebo-controlled trial of ezogabine (retigabine) in partial epilepsy","volume":"76","author":"French","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.seizure.2008.09.004","article-title":"Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials","volume":"18","author":"Gil-Nagel","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0055","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00131.x","article-title":"New tricks for old dogs: KCNQ expression and role in smooth muscle","volume":"156","author":"Greenwood","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0090-9556(24)15258-0","article-title":"Metabolism of retigabine (D-23129), a novel anticonvulsant","volume":"27","author":"Hempel","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1979.tb02904.x","article-title":"Psychomotor epilepsy and psychosis: III. Social and psychological correlates","volume":"59","author":"Kristensen","year":"1979","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/00912700222011157","article-title":"Clinical pharmacology: drugs as a benefit and\/or risk in sudden unexpected death in epilepsy","volume":"42","author":"Lathers","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/WNL.43.6.1073","article-title":"Schizophrenia in epilepsy: seizure and psychosis variables","volume":"43","author":"Mendez","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00113.x","article-title":"A pooled analysis of adjunctive topiramate in refractory partial epilepsy","volume":"108","author":"Peeters","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.wnl.0000259034.45049.00","article-title":"Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures","volume":"68","author":"Porter","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(00)00866-1","article-title":"The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2\/3 subunits","volume":"282","author":"Rundfeldt","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0100","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anticonvulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10673229309017082","article-title":"Psychiatric presentations of epilepsy","volume":"1","author":"Tisher","year":"1993","journal-title":"Harv. Rev. Psychiatry"},{"issue":"Suppl 11","key":"10.1016\/j.eplepsyres.2012.03.010_bib0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1528-1167.2005.00411.x","article-title":"Sudden unexpected death in epilepsy: a review of incidence and risk factors","volume":"46","author":"Tomson","year":"2005","journal-title":"Epilepsia"},{"year":"2005","series-title":"Atlas: Epilepsy Care in the World 2005","author":"World Health Organization","key":"10.1016\/j.eplepsyres.2012.03.010_bib0115"},{"key":"10.1016\/j.eplepsyres.2012.03.010_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.seizure.2007.12.003","article-title":"Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies","volume":"17","author":"Zaccara","year":"2008","journal-title":"Seizure"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012111200085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012111200085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:26:13Z","timestamp":1760275573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012111200085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S092012111200085X"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.03.010","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}